Evidence map›Paper›PMID 19816949›Full record

ArticleStem cells (Dayton, Ohio)2009

Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors.

Xiaohong Wang, Tiemin Zhao, Wei Huang, Tao Wang, Jiang Qian, Meifeng Xu, Evangelia G Kranias, Yigang Wang, Guo-Chang Fan

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 193 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Mesenchymal stem cells to treat liver diseases.Annals of translational medicine · 2020
    Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xiaohong WangDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0575, USA.
Tiemin Zhao
Wei Huang
Tao Wang
Jiang Qian
Meifeng Xu
Evangelia G Kranias
Yigang Wang
Guo-Chang Fan
University of Cincinnati Medical Center · USQinghai Red Cross Hospital · CN

Funding

Roles of Hsp20-Exosomes in Myocardial AngiogenesisR01HL087861 · NHLBI · UNIVERSITY OF CINCINNATI · PI FAN, GUO-CHANG · 2007 to 2017
$4.2M
Stem Cell TherapyR01HL089824 · NHLBI · UNIVERSITY OF CINCINNATI · PI WANG, YIGANG · 2008 to 2012
$1.9M
Lineage Specific Stem Cell Mobilization for Heart RepairR01HL081859 · NHLBI · UNIVERSITY OF CINCINNATI · PI WANG, YIGANG · 2005 to 2009
$1.9M
Mobilized Stem Cells in Cardiomyogenesis & AngiogenesisR01HL083236 · NHLBI · UNIVERSITY OF CINCINNATI · PI XU, MEIFENG · 2006 to 2010
$1.8M
NHLBI NIH HHS HL-081859NHLBI NIH HHS HL-083236NHLBI NIH HHS HL-087861NHLBI NIH HHS HL-089824NHLBI NIH HHS R01 HL081859NHLBI NIH HHS R01 HL083236NHLBI NIH HHS R01 HL087861NHLBI NIH HHS R01 HL089824
6 · The paper itself

Abstract

Although heat-shock preconditioning has been shown to promote cell survival under oxidative stress, the nature of heat-shock response from different cells is variable and complex. Therefore, it remains unclear whether mesenchymal stem cells (MSCs) modified with a single heat-shock protein (Hsp) gene are effective in the repair of a damaged heart. In this study, we genetically engineered rat MSCs with Hsp20 gene (Hsp20-MSCs) and examined cell survival, revascularization, and functional improvement in rat left anterior descending ligation (LAD) model via intracardial injection. We observed that overexpression of Hsp20 protected MSCs against cell death triggered by oxidative stress in vitro. The survival of Hsp20-MSCs was increased by approximately twofold by day 4 after transplantation into the infarcted heart, compared with that of vector-MSCs. Furthermore, Hsp20-MSCs improved cardiac function of infarcted myocardium as compared with vector-MSCs, accompanied by reduction of fibrosis and increase in the vascular density. The mechanisms contributing to the beneficial effects of Hsp20 were associated with enhanced Akt activation and increased secretion of growth factors (VEGF, FGF-2, and IGF-1). The paracrine action of Hsp20-MSCs was further validated in vitro by cocultured adult rat cardiomyocytes with a stress-conditioned medium from Hsp20-MSCs. Taken together, these data support the premise that genetic modification of MSCs before transplantation could be salutary for treating myocardial infarction.

Indexed as

Oxidative StressAnimalsApoptosisCardiac Surgical ProceduresCells, CulturedCoculture TechniquesEnzyme ActivationFemaleFibroblast Growth Factor 2Gene Expression RegulationHSP20 Heat-Shock ProteinsInsulin-Like Growth Factor IMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMuscle ProteinsFibroblast Growth Factor 2HSP20 Heat-Shock ProteinsHspb6 protein, ratInsulin-Like Growth Factor IMuscle ProteinsProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor Avascular endothelial growth factor A, rat

Identifiers

PMID19816949
PMCPMC2806498
OpenAlexW2032975009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.